C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice

Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling

(2016) Daniel E Croker et al.   IMMUNOLOGY AND CELL BIOLOGY

A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA

(2015) Gaurav Mehta et al.   JOURNAL OF IMMUNOLOGY

Antigen-presenting cell–derived complement modulates graft-versus-host disease

(2012) Wing-Hong Kwan et al.   JOURNAL OF CLINICAL INVESTIGATION

Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis

(2009) D. A. Copland et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Both FcγRIV and FcγRIII are essential receptors mediating type II and type III autoimmune responsesviaFcRγ-LAT-dependent generation of C5a

(2009) Shahzad N. Syed et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Protective Role of Complement C5a in an Experimental Model of Staphylococcus aureus Bacteremia

(2009) Maren von Köckritz-Blickwede et al.   Journal of Innate Immunity

The role of the anaphylatoxins in health and disease

(2009) Andreas Klos et al.   MOLECULAR IMMUNOLOGY

STIM1 is essential for Fc  receptor activation and autoimmune inflammation

(2008) A. Braun et al.   BLOOD